General InformationSidewinder Therapeutics is a Boston, MA-based RNA therapeutics biotech company founded in 2019 with approximately 51-200 employees developing novel RNA-based treatments for difficult-to-treat diseases.
Funding & FinancialsThe company has raised Series B funding; specific total amount and recent round details were not definitively confirmed in available sources but the company is actively funded in the biotech space.
Leadership & TeamSidewinder was founded by scientists and entrepreneurs focused on RNA biology and synthetic biology approaches, though specific CEO and executive names require verification from their official company page.
Recent ActivityThe company is advancing a pipeline of RNA therapeutic candidates targeting genetic and acquired diseases, with ongoing development of proprietary computational and synthetic biology platforms.